{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:08:01Z","timestamp":1792728481379,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Opioid maintenance treatment (OMT) has the potential to reduce mortality rates substantially. We aimed to compare all-cause and overdose mortality among OMT patients while in or out of OMT in two different countries with different approaches to OMT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two nation-wide, registry-based cohorts were linked by using similar analytical strategies. These included 3,637 male and 1,580 female patients enrolled in OMT in Czechia (years 2000\u20132019), and 6,387 male and 2,078 female patients enrolled in OMT in Denmark (years 2007\u20132018). The direct standardization method using the European (EU-27 plus EFTA 2011\u20132030) Standard was employed to calculate age-standardized rate to weight for age. All-cause and overdose crude mortality rates (CMR) as number of deaths per 1,000 person years (PY) in and out of OMT were calculated for all patients. CMRs were stratified by sex and OMT medication modality (methadone, buprenorphine, and buprenorphine with naloxone).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Age-standardized rate for OMT patients in Czechia and Denmark was 9.7\/1,000 PY and 29.8\/1,000 PY, respectively. In Czechia, the all-cause CMR was 4.3\/1,000 PY in treatment and 10.8\/1,000 PY out of treatment. The overdose CMR was 0.5\/1,000 PY in treatment and 1.2\/1,000 PY out of treatment. In Denmark, the all-cause CMR was 26.6\/1,000 PY in treatment and 28.2\/1,000 PY out of treatment and the overdose CMR was 7.3\/1,000 PY in treatment and 7.0\/1,000 PY out of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Country-specific differences in mortality while in and out of OMT in Czechia and Denmark may be partly explained by different patient characteristics and treatment systems in the two countries. The findings contribute to the public health debate about OMT management and may be of interest to practitioners, policy and decision makers when balancing the safety and accessibility of OMT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1179763","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T03:28:25Z","timestamp":1695612505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Large variations in all-cause and overdose mortality among &gt;13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study"],"prefix":"10.3389","volume":"11","author":[{"given":"Roman","family":"Gabrhel\u00edk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanka","family":"Nechansk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte","family":"Handal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Mrav\u010d\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tjagvad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Thylstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdu Kedir","family":"Seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bukten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies: mortality among opioid users","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"ref2","unstructured":"Vereinte NationenB. f\u00fcr D. und V.\n          World drug report2018"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/nyas.14209","article-title":"Epidemiology of the U.S. opioid crisis: the importance of the vector","volume":"1451","author":"Compton","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","article-title":"All-cause and cause-specific mortality among people using Extramedical opioids: a systematic review and Meta-analysis","volume":"77","author":"Larney","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/add.12337","article-title":"Causes of death in a cohort treated for opioid dependence between 1985 and 2005: mortality among opioid-dependent people","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"ref6","volume-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","year":"2009"},{"key":"ref7","unstructured":"Balancing access to opioid substitution treatment with preventing the diversion of opioid substitution medications in Europe: challenges and implications2021"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/add.12788","article-title":"The role of Cochrane reviews in informing international guidelines: a case study of using the grading of recommendations, assessment, development and evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmac: Cochrane and GRADE for addiction guidelines","volume":"110","author":"Davoli","year":"2015","journal-title":"Addiction"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000446429","article-title":"Methadone-related overdose deaths in a Liberal opioid maintenance treatment Programme","volume":"22","author":"Tjagvad","year":"2016","journal-title":"Eur Addict Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of Opioid Agonist Treatment with all-Cause Mortality and Specific Causes of death among people with opioid dependence: a systematic review and Meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"ref13","unstructured":"2017"},{"key":"ref14","unstructured":"2019"},{"key":"ref15","first-page":"215","article-title":"Problem opioid use in the Czech Republic from a historical perspective: times are changing but opioid pharmaceuticals remain","volume":"18","author":"Malinovsk\u00e1","year":"2018","journal-title":"Adiktologie"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/145507250402101s16","article-title":"Buprenorphine treatment in Denmark","volume":"21","author":"Thiesen","year":"2004","journal-title":"Nordic Stud Alcohol Drugs"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","article-title":"Buprenorphine pharmacology review: update on Transmucosal and long-acting formulations","volume":"13","author":"Coe","year":"2019","journal-title":"J Addict Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"549272","DOI":"10.3389\/fpsyt.2020.549272","article-title":"Reconsidering the usefulness of adding naloxone to buprenorphine","volume":"11","author":"Blazes","year":"2020","journal-title":"Front Psych"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/add.14188","article-title":"The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom: burpenorphine vs methadone on mortality risk","volume":"113","author":"Hickman","year":"2018","journal-title":"Addiction"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e047028","DOI":"10.1136\/bmjopen-2020-047028","article-title":"Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study","volume":"11","author":"Gabrhel\u00edk","year":"2021","journal-title":"BMJ Open"},{"key":"ref22","volume-title":"Souhrnn\u00e1 zpr\u00e1va o z\u00e1vislostech v \u010cesk\u00e9 republice 2022 [Summary Report on Addictions in the Czech Republic in 2022]","author":"Chomynov\u00e1","year":"2023"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"108792","DOI":"10.1016\/j.drugalcdep.2021.108792","article-title":"A retrospective cohort study of medication dispensing at pharmacies: administration matters!","volume":"225","author":"Hesse","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"ref24","unstructured":"V\u011bstn\u00edk MZ \u010cR \u010d\u00e1stka 3\/2008\u2014Standard substitu\u010dn\u00ed l\u00e9\u010dby [Journal of the Ministry of Health of the Czech Republic issue 3\/2008\u2014Standard of substitution treatment]2008"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0268-0","article-title":"The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic","volume":"15","author":"Mrav\u010d\u00edk","year":"2018","journal-title":"Harm Reduct J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3109\/10826084.2013.797838","article-title":"Shifts in opioid substitution treatment policy in Denmark from 2000\u20132011","volume":"48","author":"Frank","year":"2013","journal-title":"Subst Use Misuse"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/009145091404100104","article-title":"Rationalities of choice and practices of care: substitution treatment in Denmark","volume":"41","author":"Bjerge","year":"2014","journal-title":"Contemp Drug Probl"},{"key":"ref28","year":"2013"},{"key":"ref29","author":"Thylstrup","year":"2015"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.addbeh.2014.05.007","article-title":"Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study","volume":"39","author":"Bukten","year":"2014","journal-title":"Addict Behav"},{"key":"ref32","unstructured":"2009"},{"key":"ref33","unstructured":"2013"},{"key":"ref34","volume-title":"IBM SPSS statistics for windows, version 24.0","year":"2016"},{"key":"ref35","volume-title":"Stata statistical software: Release 16","year":"2019"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12913-019-4382-9","article-title":"From restrictive to more liberal: variations in mortality among patients in opioid maintenance treatment over a 12-year period","volume":"19","author":"Bukten","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1517\/14740338.2015.1037274","article-title":"Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review","volume":"14","author":"Kim","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12889-021-10497-2","article-title":"Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review","volume":"21","author":"Moustaqim-Barrette","year":"2021","journal-title":"BMC Public Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archinte.1966.00290160004002","article-title":"Narcotic blockade","volume":"118","author":"Dole","year":"1966","journal-title":"Arch Intern Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000509048","article-title":"Prenatal methamphetamine exposure and adverse neonatal outcomes: a Nationwide cohort study","volume":"27","author":"Gabrhel\u00edk","year":"2020","journal-title":"Eur Addict Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.drugalcdep.2020.107933","article-title":"Socioeconomic characteristics of women with substance use disorder during pregnancy and neonatal outcomes in their newborns: a national registry study from the Czech Republic","volume":"209","author":"Mrav\u010d\u00edk","year":"2020","journal-title":"Drug Alcohol Depend"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1179763\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T03:28:35Z","timestamp":1695612515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1179763\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2023.1179763"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1179763","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"article-number":"1179763"}}